Decreased serum levels of thrombospondin‐1 in female depressed patients
Abstract Aim Thrombospondin‐1 (TSP‐1) is an astrocyte‐derived synaptogenesis‐related factor. It was previously reported to be increased by chronic treatment of electroconvulsive seizure, a model of electroconvulsive therapy (ECT), in rat hippocampus. The aim of this study was to examine whether seru...
Main Authors: | Mami Okada‐Tsuchioka, Wataru Omori, Naoto Kajitani, Chiyo Shibasaki, Kei Itagaki, Minoru Takebayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Neuropsychopharmacology Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/npr2.12088 |
Similar Items
-
Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
by: Hiromi Abe, et al.
Published: (2023-09-01) -
Research progress on the role of thrombospondin 2 in malignant tumors
by: MA Jiajunyan, RUI Tiannan, ZHANG Yongsheng
Published: (2023-12-01) -
Relationship of thrombospondin-1 and thrombospondin-2 with hematological, biochemical and inflammatory markers in COVID-19 patients
by: Dogan Serdar, et al.
Published: (2023-06-01) -
The Evaluation of Thrombospondin 1 Levels in Patients with Acromegaly
by: Mustafa Demirpençe, et al.
Published: (2020-01-01) -
Thrombospondin expression in myofibers stabilizes muscle membranes
by: Davy Vanhoutte, et al.
Published: (2016-09-01)